Clinical Trial Information Request for Protocol 21-040 Title A Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab in patients with relapsed/refractory and previously untreated mantle cell lymphoma PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone